These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20674607)

  • 1. Reverse phase protein microarray technology in traumatic brain injury.
    Gyorgy AB; Walker J; Wingo D; Eidelman O; Pollard HB; Molnar A; Agoston DV
    J Neurosci Methods; 2010 Sep; 192(1):96-101. PubMed ID: 20674607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades.
    Agoston DV; Gyorgy A; Eidelman O; Pollard HB
    J Neurotrauma; 2009 Jun; 26(6):901-11. PubMed ID: 19397421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematically generated antibodies against human gene products: high throughput screening on sections from the rat nervous system.
    Mulder J; Wernérus H; Shi TJ; Pontén F; Hober S; Uhlén M; Hökfelt T
    Neuroscience; 2007 Jun; 146(4):1689-703. PubMed ID: 17478047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody microarray analysis of directly labelled complex proteomes.
    Wingren C; Borrebaeck CA
    Curr Opin Biotechnol; 2008 Feb; 19(1):55-61. PubMed ID: 18187318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data merging for integrated microarray and proteomic analysis.
    Waters KM; Pounds JG; Thrall BD
    Brief Funct Genomic Proteomic; 2006 Dec; 5(4):261-72. PubMed ID: 16772273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a protein chip: a MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach.
    Warren EN; Elms PJ; Parker CE; Borchers CH
    Anal Chem; 2004 Jul; 76(14):4082-92. PubMed ID: 15253646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of blocking and detection chemistries on antibody performance for reverse phase protein arrays.
    Ambroz K
    Methods Mol Biol; 2011; 785():13-21. PubMed ID: 21901590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated signal amplification for reverse phase protein array-based protein quantification.
    Brase JC; Mannsperger H; Sültmann H; Korf U
    Methods Mol Biol; 2011; 785():55-64. PubMed ID: 21901593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and quality control of protein microarray-based analytical methods.
    Kricka LJ; Master SR
    Methods Mol Med; 2005; 114():233-55. PubMed ID: 16156108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly sensitive near-infrared fluorescent detection method to analyze signalling pathways by reverse-phase protein array.
    Dupuy L; Gauthier C; Durand G; Musnier A; Heitzler D; Herledan A; Sakanyan V; Crépieux P; Reiter E
    Proteomics; 2009 Dec; 9(24):5446-54. PubMed ID: 19834902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
    Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
    Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in computational inference from mass spectrometry-based proteomics.
    Webb-Robertson BJ; Cannon WR
    Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A concentration-dependent analysis method for high density protein microarrays.
    Marina O; Biernacki MA; Brusic V; Wu CJ
    J Proteome Res; 2008 May; 7(5):2059-68. PubMed ID: 18393456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput gene and protein expression analysis in pulp biologic research: review.
    Pääkkönen V; Tjäderhane L
    J Endod; 2010 Feb; 36(2):179-89. PubMed ID: 20113773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.
    Hood BL; Stewart NA; Conrads TP
    Clin Lab Med; 2009 Mar; 29(1):115-38. PubMed ID: 19389555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein and lysate array technologies in cancer research.
    Spurrier B; Honkanen P; Holway A; Kumamoto K; Terashima M; Takenoshita S; Wakabayashi G; Austin J; Nishizuka S
    Biotechnol Adv; 2008; 26(4):361-9. PubMed ID: 18514460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Micro-array based technologies to study the proteome: technological progress and applications].
    Mortuaire G; Marchetti P; Formstecher P; Danzé PM
    Ann Biol Clin (Paris); 2004; 62(2):139-48. PubMed ID: 15047465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering and Network Analysis of Reverse Phase Protein Array Data.
    Byron A
    Methods Mol Biol; 2017; 1606():171-191. PubMed ID: 28502001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional protein identification technology: current status and future prospects.
    Kislinger T; Emili A
    Expert Rev Proteomics; 2005 Jan; 2(1):27-39. PubMed ID: 15966850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.